• Citer

Febrile neutropenia (FN) occurrence outside of clinical trials: Occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study

par Rapoport, Bernardo Leon B.;Aapro, Matty;Paesmans, Marianne ;van Eeden, Ronwyn;Smit, Teresa;Krendyukov, Andriy;Klastersky, Jean
Référence BMC cancer, 18, 1, 917
Publication Publié, 2018-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Febrile neutropenia (FN) occurrence outside of clinical trials: Occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study
Auteur:	Rapoport, Bernardo Leon B.; Aapro, Matty; Paesmans, Marianne; van Eeden, Ronwyn; Smit, Teresa; Krendyukov, Andriy; Klastersky, Jean
Informations sur la publication:	BMC cancer, 18, 1, 917
Statut de publication:	Publié, 2018-09
Sujet CREF:	Biologie
	Cancérologie
Mots-clés:	Chemotherapy
	Chemotherapy-induced neutropenia
	Cytotoxic chemotherapy
	Febrile neutropenia
	Myelosuppressive chemotherapy
	Neutropenia
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1471-2407
	info:doi/10.1186/s12885-018-4838-z
	info:scp/85053768747
	info:pmid/30249215